Pigmentation phototype and prostate and breast cancer in a select Spanish population: A Mendelian randomization analysis in the MCC-Spain study

Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. Methods We examined the association between the phototype and breast and p...

Descripción completa

Detalles Bibliográficos
Autores: Gómez-Acebo, Inés, Dierssen-Sotos, Trinidad, Palazuelos, Camilo, Fernández-Navarro, Pablo, Castaño-Vinyals, Gemma, Alonso-Molero, Jéssica, Urtiaga, Carmen, Fernández-Villa, Tania, Ardanaz, Eva, Rivas-del-Fresno, Manuel, Molina-Barceló, Ana, Jiménez-Moleón, José Juan, García-Martínez, Lidia, Amiano, Pilar, Rodríguez-Cundín, Paz, Moreno, Víctor, Pérez-Gómez, Beatriz, Aragonés, Nuria, Kogevinas, Manolis, Pollán Santamaría, Marina Anunciación, Llorca, Javier
Tipo de recurso: artículo
Fecha de publicación:2018
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/687678
Acceso en línea:http://hdl.handle.net/10486/687678
https://dx.doi.org/10.1371/journal.pone.0201750
Access Level:acceso abierto
Palabra clave:Prostate cancer
Phototype and breast
Genetic pigmentation
Mendelian randomization analysis
Medicina
Descripción
Sumario:Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. Methods We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype—cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer. Results The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate. Conclusions Phototype is not associated with breast or prostate cancer.